Clinical Trials for Drug: Bevacizumab

3 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
ECOG-EAF151 (CIRB) Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma Open
UCI-13-14 A Randomized, Double-blinded, Placebo-controlled Phase 2 study of (ERC1671/ GM-CSF / Cyclophosphamide) + Bevacizumab vs. (Placebo Injection / Placebo pill) + Bevacizumab in the treatment of recurrent/progressive, Bevacizumab naïve glioblastoma multiforme and gliosarcoma patients (WHO grade IV malignant gliomas) Open
UCI-14-67 A Phase II Study of Breast Cancer Treatment Using Weekly Carboplatin + Paclitaxel with Pertuzumab + Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting Open